Publication | Closed Access

Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure

Surgical OncologySunitinib MalateGastrointestinal OncologyImatinib FailureMedicineCancer ManagementPathologyContinuous Daily DosingCancer TreatmentOncologyRadiation OncologyCancer Research